Executive Vice President, R&D
In 1991, Johan Luthman began his career in the pharmaceutical industry in Astra, later AstraZeneca. In 2005, Johan became Head of Neuroscience Research at Merck Serono. In 2009, he became CEO of biotech start-up GeNeuro. From mid-2009 Johan joined Merck as VP & Franchise Integrator for Neuroscience and Opthamology. In 2014, he came to Eisai where he was Senior Vice President and Head of Clinical Development. Johan joined Lundbeck as Executive Vice President, R&D in March 2019.
Johan is a Swedish national and is trained as a Doctor of Dental Sciences from the Karolinska Institute, Sweden. He further holds a PhD in Neurobiology and Histology also from the Karolinska Institute, Sweden.